Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein–Barr virus-associated T cell and natural killer cell lymphoma
Version of Record online: 12 MAY 2014
© 2014 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Volume 105, Issue 6, pages 713–722, June 2014
How to Cite
Cancer Sci 105 (2014) 713–722
Ministry of Education, Culture, Sports, Science and Technology of Japan (25293109). Ministry of Health, Labour and Welfare of Japan (H24-Nanchi-046).
- Issue online: 4 JUN 2014
- Version of Record online: 12 MAY 2014
- Accepted manuscript online: 8 APR 2014 12:01PM EST
- Manuscript Accepted: 7 APR 2014
- Manuscript Revised: 31 MAR 2014
- Manuscript Received: 26 FEB 2014
- Ministry of Education, Culture, Sports, Science and Technology of Japan. Grant Number: 25293109
- Ministry of Health, Labour and Welfare of Japan. Grant Number: H24-Nanchi-046
|cas12418-sup-0001-FigS1.tif||image/tif||102K||Fig. S1. SNK6 is less dependent of human interleukin-2 (IL-2) compared with other Epstein–Barr virus (EBV)-positive T and natural killer (NK) cell lines.|
|cas12418-sup-0002-TableS1.docx||Word document||12K||Table S1. Engraftment of cell lines into NOG mice.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.